- Home
- Research
- Research that Transforms
- Beyond the Bench
- Beyond the Bench 2021
- Physician-Scientists: Bridging the Lab and Clinic
Physician-Scientists: Bridging the Lab and Clinic
Physician-scientists bring a unique perspective to research. Bridging the clinic and the laboratory, they are essential to translational research. In these dual roles, physician-scientists use their clinical observations to frame research questions and design their own clinical trials. Meet some of The University of Kansas Cancer Center’s physician-scientists who are tirelessly working on tomorrow’s breakthroughs in cancer.
David Akhavan, MD, PhD
The consummate physician-scientist is compassionate and adept at patient care, yet also has the technical ability to find novel therapies in the laboratory from lessons learned in the clinic. Through my work in these two environments, I hope to find curative therapies for people with brain tumors. David Akhavan, MD, PhD
Andrea Jewell, MD
My experiences with patients in the clinic mean I bring more depth to the research questions we are trying to answer. As a physician-scientist at a National Cancer Institute-designated center, I have access to research funding and clinical trials that other cancer centers do not. This is vitally important when developing a career in research and medicine, and it helps us complete more clinically impactful research. Andrea Jewell, MD
Gregory Gan, MD, PhD
Ever since I was a kid, I knew I wanted to pursue medicine. In college, I interned for a biotech company where they were using the latest molecular biology techniques to understand the process of claudication due to severe peripheral artery disease. This was an amazing marriage of medicine and science to improve human health. I knew this was the career path for me. Gregory Gan, MD, PhD
Shane Stecklein, MD, PhD
I am committed to providing my patients with the best treatment available today. But I recognize that we can do better than what we have today. I became a physician-scientist so I could use my curiosity for cancer biology to find ways to improve cure rates, reduce side effects and cost of treatment, and ultimately help my future patients do better than the patients I treat today. Shane Stecklein, MD, PhD